Inventor · disambiguated record
Makoto Kakitani
Also filed as: KAKITANI MAKOTO
8 granted patents·16 pending applications·744 citations·filing 1990–2017
88Inventor score
Top patents by PatentIndex Score
24 records- 0196US5824778AChemically-modified G-CSFKIRIN AMGEN INC·Filed 1992·Granted Oct 20, 1998·443 cites·2 claims
- 0294US6166183AChemically-modified G-CSFKIRIN AMGEN INC·Filed 1997·Granted Dec 26, 2000·192 cites·4 claims
- 0392US7951381B2Method of stimulating epithelial cell proliferation by administration of gastrointestinal proliferative factorKYOWA HAKKO KIRIN CO LTD·Filed 2009·Granted May 31, 2011·18 cites·7 claims
- 0485US5264209AModified HIL-6KIRIN AMGEN INC·Filed 1990·Granted Nov 23, 1993·86 cites·20 claims
- 0564US2011237514A1PHARMACEUTICAL COMPOSITION FOR TREATING BONE DISEASES WHICH COMPRISES PROTEIN COMPRISING Frizzled1, Frizzled2 OR Frizzled7 EXTRACELLULAR CYSTEINE-RICH DOMAINKYOWA HAKKO KIRIN CO LTD·Filed 2009·Application pending·0 cites
- 0664US2004158041A1Chemically modified G-CSFKIRIN AMGEN INC·Filed 2004·Application pending·0 cites
- 0764US2004204566A1Chemically-modified G-CSFKIRIN AMGEN INC·Filed 2004·Application pending·0 cites
- 0862US10646544B2Pharmaceutical composition for treating bone diseases which comprises protein comprising Frizzled 1, Frizzled 2 or Frizzled 7 extracellular cysteine-rich domainKYOWA HAKKO KIRIN CO LTD·Filed 2017·Granted May 12, 2020·0 cites·12 claims
- 0960US9700594B2Pharmaceutical composition for treating bone diseases which comprises protein comprising Frizzled1, Frizzled2 or Frizzled7 extracellular cysteine-rich domainKYOWA HAKKO KIRIN CO LTD·Filed 2013·Granted Jul 11, 2017·0 cites·13 claims
- 1060US2003204057A1Chemically modified G-CSFKIRIN AMGEN INC·Filed 2003·Application pending·0 cites
- 1160US2010011452A1Chimeric non-human animalKYOWA HAKKO KIRIN CO LTD·Filed 2009·Application pending·0 cites
- 1259US2008300183A1Gastrointestinal proliferative factor and uses thereofKIRIN PHARMA KK·Filed 2007·Application pending·0 cites
- 1359US2006247422A1Chemically modified G-CSFKIRIN AMGEN INC·Filed 2006·Application pending·0 cites
- 1456US2002177688A1Chemically-modified G-CSFKIRIN AMGEN INC·Filed 2001·Application pending·0 cites
- 1554US2005256044A1Gastrointestinal proliferative factor and uses thereofBOYLE BRYAN J·Filed 2005·Application pending·0 cites
- 1654US2005256036A1Gastrointestinal proliferative factor and uses thereofBOYLE BRYAN J·Filed 2005·Application pending·0 cites
- 1753US2007219357A1Chemically modified G-CSFKIRIN AMGEN INC·Filed 2007·Application pending·0 cites
- 1851US2009151011A1Chimeric Non-Human Animal and Use ThereofKIRIN PHARMA KK·Filed 2006·Application pending·0 cites
- 1947US6225531B1Glucan elicitor receptor, DNA molecule coding therefor, fungus-resistant plants transformed with the DNA molecule and method for creating the plantsKIRIN BREWERY·Filed 1998·Granted May 1, 2001·5 cites·16 claims
- 2046US2005177884A1Chimeric nonhuman animalKIRIN BREWERY·Filed 2002·Application pending·0 cites
- 2144US2009036369A1Anti-tumor agents comprising r-spondinsKIRIN PHARMA KK·Filed 2006·Application pending·0 cites
- 2244US2006123490A1Pluripotent cells with improved efficiency of homologous recombination and use of the sameKIRIN BREWERY·Filed 2005·Application pending·0 cites
- 2342US2002104122A1Methods for producing a plant with enhanced resistance to pathogenic fungiKIRIN BREWERY·Filed 2001·Application pending·0 cites
- 2426US9428560B2Protein comprising truncated form of extracellular region protein of Frizzled 2, and pharmaceutical composition for treating bone diseases which comprises said proteinKAKITANI MAKOTO·Filed 2012·Granted Aug 30, 2016·0 cites·11 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →